| Tumor suppressive miR-196a is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma | kidney, |
| miR-196 acts as a tumor suppressor in osteosarcoma by targeting HOXA9 | osteosarcoma, |
| Combination of tumor suppressor miR-20b-5p, miR-30a-5p, and miR-196a-5p as a serum diagnostic panel for renal cell carcinoma | kidney, |
| Data show that miR-196a exerts a pro-oncogenic influence in colorectal cancer. | colorectal, |
| High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. | colorectal, |
| Aberrant expression of miR-196a in gastric cancers and correlation with recurrence. | gastric, |
| data demonstrate that miR-196a exerts an oncogenic role in gastric cancer | gastric, |
| MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibiting IkappaBalpha both in vitro and in vivo. | glioblastoma, |
| MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IkappaBalpha both in vitro and in vivo. | glioblastoma, |
| MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance. | HNSC, |